← All trials
NCT03071666
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 27, 2017
- Primary completion
- Jun 28, 2021
- Completion date
- Dec 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 600
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of BergenLead sponsor
- University of BergenOverall official - principal investigator
- Tribhuvan UniversityOverall official - principal investigator
- Kathmandu UniversityOverall official - principal investigator
- Uni ResearchCollaborator
- Sykehuset Innlandet HFCollaborator
- Tribhuvan UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.